Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · Real-Time Price · USD
2.390
0.00 (0.00%)
At close: May 22, 2026, 4:00 PM EDT
2.450
+0.060 (2.51%)
After-hours: May 22, 2026, 7:57 PM EDT

Moleculin Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
10.328.884.2823.5543.1570.9
Cash & Short-Term Investments
10.328.884.2823.5543.1570.9
Cash Growth
33.71%107.53%-81.83%-45.42%-39.15%367.30%
Other Current Assets
0.640.810.922.722.451.59
Total Current Assets
10.969.695.1926.2745.672.5
Net Property, Plant & Equipment
0.350.390.580.80.680.45
Other Intangible Assets
11.1511.1511.1511.1511.1511.15
Other Long-Term Assets
0.90.9----
Total Assets
23.3622.1316.9338.2257.4284.09
Accounts Payable
4.573.512.032.52.11.36
Accrued Expenses
3.393.353.334.322.722.26
Total Current Liabilities
7.966.855.366.824.823.62
Long-Term Leases
0.190.220.360.470.340.06
Other Long-Term Liabilities
0.030.04-4.860.081.41
Total Long-Term Liabilities
0.220.270.365.330.411.48
Total Liabilities
8.187.125.7212.145.235.1
Common Stock
0.010-0.030.030.03
Additional Paid-in Capital
234.08221183.69157.65153.99151.73
Accumulated Other Comprehensive Income
-0.050.01-0.04-0.010.010.04
Retained Earnings
----131.6-101.84-72.81
Total Common Shareholders' Equity
15.1815.0111.2126.0752.1978.99
Shareholders' Equity
234.03221.01183.6526.0752.1978.99
Total Liabilities & Equity
23.3622.1316.9338.2257.4284.09
Total Debt
0.190.220.360.470.340.06
Net Cash (Debt)
10.138.663.9223.0842.8170.84
Net Cash Growth
17.05%120.82%-83.01%-46.10%-39.57%371.83%
Net Cash Per Share
4.787.3128.46292.01561.23988.43
Book Value
15.1815.0111.2126.0752.1978.99
Book Value Per Share
7.1612.6781.38329.94684.221102.19
Tangible Book Value
4.043.860.0614.9341.0467.85
Tangible Book Value Per Share
1.903.260.44188.87538.07946.64
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q